thymidine has been researched along with sermorelin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pence, JC; Shorter, NA | 1 |
| Armatis, P; Groot, K; Halmos, G; Pinski, J; Schally, AV; Szepeshazi, K; Zarandi, M | 1 |
| Armatis, P; Groot, K; Halmos, G; Jungwirth, A; Pinski, J; Schally, AV | 1 |
3 other study(ies) available for thymidine and sermorelin
| Article | Year |
|---|---|
Further studies on the interaction between vasoactive intestinal peptide and neuroblastoma cell lines.
Topics: Cell Differentiation; Cell Division; Cell Line; DNA Replication; Drug Synergism; Glucagon; Growth Hormone-Releasing Hormone; Humans; Kinetics; Neuroblastoma; Peptide Fragments; Secretin; Sermorelin; Thymidine; Tretinoin; Vasoactive Intestinal Peptide | 1991 |
Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone.
Topics: Animals; Cyclic AMP; Growth Hormone-Releasing Hormone; Hormone Antagonists; Humans; Insulin-Like Growth Factor I; Male; Mice; Mice, Nude; Osteosarcoma; Rabbits; Receptor, IGF Type 1; Sermorelin; Thymidine; Tumor Cells, Cultured | 1995 |
Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma.
Topics: Animals; Carcinoma, Renal Cell; Cell Division; Cell Membrane; DNA, Neoplasm; Growth Hormone; Growth Hormone-Releasing Hormone; Hormone Antagonists; Humans; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Kidney Neoplasms; Liver; Male; Mice; Mice, Nude; Receptor, IGF Type 1; Sermorelin; Thymidine; Transplantation, Heterologous; Tumor Cells, Cultured | 1997 |